Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Decoding the Information Contained in Fluorophore Radiation Patterns.

Brunstein M, Salomon A, Oheim M.

ACS Nano. 2018 Dec 26;12(12):11725-11730. doi: 10.1021/acsnano.8b08696.

PMID:
30995713
2.

Near-Membrane Refractometry Using Supercritical Angle Fluorescence.

Brunstein M, Roy L, Oheim M.

Biophys J. 2017 May 9;112(9):1940-1948. doi: 10.1016/j.bpj.2017.03.008.

3.

Dependence of descriptors of co-localization on microscope spatiotemporal resolution and the choice of regions of interest.

Brunstein M, Oheim M.

Microsc Res Tech. 2017 Feb;80(2):220-230. doi: 10.1002/jemt.22790. Epub 2016 Nov 8.

PMID:
27859992
4.

Improving image contrast in fluorescence microscopy with nanostructured substrates.

Brunstein M, Cattoni A, Estrada L, Yacomotti AM.

Opt Express. 2015 Nov 16;23(23):29772-8. doi: 10.1364/OE.23.029772.

PMID:
26698460
6.

Eliminating unwanted far-field excitation in objective-type TIRF. Part I. identifying sources of nonevanescent excitation light.

Brunstein M, Teremetz M, Hérault K, Tourain C, Oheim M.

Biophys J. 2014 Mar 4;106(5):1020-32. doi: 10.1016/j.bpj.2013.12.049.

7.

Full-field dual-color 100-nm super-resolution imaging reveals organization and dynamics of mitochondrial and ER networks.

Brunstein M, Wicker K, Hérault K, Heintzmann R, Oheim M.

Opt Express. 2013 Nov 4;21(22):26162-73. doi: 10.1364/OE.21.026162.

PMID:
24216840
8.

Impairment in psychosocial functioning in patients with different subtypes of eating disorders.

Moser CM, Lobato MI, Rosa AR, Thomé E, Ribar J, Primo L, Santos AC, Brunstein MG.

Trends Psychiatry Psychother. 2013;35(2):111-8.

9.

Enhancement of a nano cavity lifetime by induced slow light and nonlinear dispersions.

Grinberg P, Bencheikh K, Brunstein M, Yacomotti AM, Dumeige Y, Sagnes I, Raineri F, Bigot L, Levenson JA.

Opt Express. 2012 Nov 19;20(24):27403-10. doi: 10.1364/OE.20.027403.

PMID:
23187597
10.

Nanocavity linewidth narrowing and group delay enhancement by slow light propagation and nonlinear effects.

Grinberg P, Bencheikh K, Brunstein M, Yacomotti AM, Dumeige Y, Sagnes I, Raineri F, Bigot L, Levenson JA.

Phys Rev Lett. 2012 Sep 14;109(11):113903. Epub 2012 Sep 13.

PMID:
23005630
11.

Contrasted effects of the multitarget TKi vandetanib on docetaxel-sensitive and docetaxel-resistant prostate cancer cell lines.

Guérin O, Etienne-Grimaldi MC, Monteverde M, Sudaka A, Brunstein MC, Formento P, Lattanzio L, Maffi M, Tonissi F, Ortholan C, Pagès G, Fischel JL, Lo Nigro C, Merlano M, Milano G.

Urol Oncol. 2013 Nov;31(8):1567-75. doi: 10.1016/j.urolonc.2012.03.003. Epub 2012 May 17.

PMID:
22608542
12.

Development and validity data of the Brazilian Internet Study on Temperament and Psychopathology (BRAINSTEP).

Lara DR, Ottoni GL, Brunstein MG, Frozi J, de Carvalho HW, Bisol LW.

J Affect Disord. 2012 Dec 10;141(2-3):390-8. doi: 10.1016/j.jad.2012.03.011. Epub 2012 Mar 27.

PMID:
22460054
13.

The Affective and Emotional Composite Temperament (AFECT) model and scale: a system-based integrative approach.

Lara DR, Bisol LW, Brunstein MG, Reppold CT, de Carvalho HW, Ottoni GL.

J Affect Disord. 2012 Sep;140(1):14-37. doi: 10.1016/j.jad.2011.08.036. Epub 2011 Oct 5. Review.

PMID:
21978734
14.

Antitumor activity of cetuximab associated with the taxotere-cisplatin-fluorouracil (TPF) combination on an orthotopic head and neck cancer model.

Bozec A, Sudaka A, Etienne-Grimaldi MC, Brunstein MC, Fischel JL, Milano G.

Oral Oncol. 2011 Oct;47(10):940-5. doi: 10.1016/j.oraloncology.2011.07.028. Epub 2011 Sep 8.

PMID:
21862388
15.

Small volume excitation and enhancement of dye fluorescence on a 2D photonic crystal surface.

Estrada LC, Martinez OE, Brunstein M, Bouchoule S, Le-Gratiet L, Talneau A, Sagnes I, Monnier P, Levenson JA, Yacomotti AM.

Opt Express. 2010 Feb 15;18(4):3693-9. doi: 10.1364/OE.18.003693.

PMID:
20389379
16.

Thermo-optical dynamics in an optically pumped Photonic Crystal nano-cavity.

Brunstein M, Braive R, Hostein R, Beveratos A, Rober-Philip I, Sagnes I, Karle TJ, Yacomotti AM, Levenson JA, Moreau V, Tessier G, De Wilde Y.

Opt Express. 2009 Sep 14;17(19):17118-29. doi: 10.1364/OE.17.017118.

PMID:
19770929
17.

Anomalous dynamics of melanosomes driven by myosin-V in Xenopus laevis melanophores.

Brunstein M, Bruno L, Desposito M, Levi V.

Biophys J. 2009 Sep 16;97(6):1548-57. doi: 10.1016/j.bpj.2009.06.048.

18.

Transition to superdiffusive behavior in intracellular actin-based transport mediated by molecular motors.

Bruno L, Levi V, Brunstein M, Despósito MA.

Phys Rev E Stat Nonlin Soft Matter Phys. 2009 Jul;80(1 Pt 1):011912. Epub 2009 Jul 17.

PMID:
19658734
19.

Is flunarizine a long-acting oral atypical antipsychotic? A randomized clinical trial versus haloperidol for the treatment of schizophrenia.

Bisol LW, Brunstein MG, Ottoni GL, Ramos FL, Borba DL, Daltio CS, de Oliveira RV, Paz GE, de Souza SE, Bressan RA, Lara DR.

J Clin Psychiatry. 2008 Oct;69(10):1572-9. Epub 2008 Sep 1.

PMID:
19192440
20.

Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression.

Fantozzi I, Grall D, Cagnol S, Stanchi F, Sudaka A, Brunstein MC, Bozec A, Fischel JL, Milano G, Van Obberghen-Schilling E.

Acta Oncol. 2008;47(8):1502-12. doi: 10.1080/02841860802089801.

PMID:
18607838
21.

Combined effects of bevacizumab with erlotinib and irradiation: a preclinical study on a head and neck cancer orthotopic model.

Bozec A, Sudaka A, Fischel JL, Brunstein MC, Etienne-Grimaldi MC, Milano G.

Br J Cancer. 2008 Jul 8;99(1):93-9. doi: 10.1038/sj.bjc.6604429. Epub 2008 Jun 24.

22.

A case series on the hypothesized connection between dementia and bipolar spectrum disorders: bipolar type VI?

Ng B, Camacho A, Lara DR, Brunstein MG, Pinto OC, Akiskal HS.

J Affect Disord. 2008 Apr;107(1-3):307-15. Epub 2007 Sep 21.

PMID:
17889374
23.

Increased serum adenosine deaminase activity in schizophrenic receiving antipsychotic treatment.

Brunstein MG, Silveira EM Jr, Chaves LS, Machado H, Schenkel O, Belmonte-de-Abreu P, Souza DO, Lara DR.

Neurosci Lett. 2007 Feb 27;414(1):61-4. Epub 2007 Jan 8.

PMID:
17289263
24.

Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications.

Lara DR, Dall'Igna OP, Ghisolfi ES, Brunstein MG.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jun;30(4):617-29. Epub 2006 Mar 6. Review.

PMID:
16580767
25.

A clinical trial of adjuvant allopurinol therapy for moderately refractory schizophrenia.

Brunstein MG, Ghisolfi ES, Ramos FL, Lara DR.

J Clin Psychiatry. 2005 Feb;66(2):213-9.

PMID:
15705007
26.

Allopurinol augmentation for poorly responsive schizophrenia.

Lara DR, Brunstein MG, Ghisolfi ES, Lobato MI, Belmonte-de-Abreu P, Souza DO.

Int Clin Psychopharmacol. 2001 Jul;16(4):235-7.

PMID:
11459338
27.

Therapeutic benefit of adjunctive dipyridamole in schizophrenia is probably due to adenosine-glutamate interactions.

Brunstein MG, Belmonte-de-Abreu P, Souza DO, Lara DR.

J Clin Pharm Ther. 2001 Apr;26(2):155-6. No abstract available.

PMID:
11350540

Supplemental Content

Loading ...
Support Center